External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology APVRS 2024
Roche and Genentech at

APVRS 2024

November 22 - November 24
Singapore, Singapore
2024.apvrs.org
We will be contributing to topics related to
Ophthalmology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
03:30 AM
Duration 5mins Rapid Fire 3 - Retina (Medical) (1)
Patient Preference for the Port Delivery System With Ranibizumab (PDS) vs Intravitreal Injections: 1-Year Results From the Phase 3 Pagoda Trial in Patients With Diabetic Macular Edema (DME)
Koh A, Chang M, Marcus D, Baldonado K, Daly A, Tian K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:45 AM
Duration 5mins Rapid Fire 3 - Retina (Medical) (1)
Port Delivery System With Ranibizumab for Continuous Treatment in Diabetic Retinopathy: First Readout of 2-Year Data From the Phase 3 Pavilion Trial
Lai T, Chang M, Awh C, Khanani A, Tian K, Latkany P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.